Pioneering the Future of Human Longevity

NovaGen Group advances longevity science through cellular research, AI health intelligence, and partner-network education.

Our Mission

Democratizing Longevity Science

From Lab Discovery to Global Access—The NovaGen Group Story

Responsible Access

Building partner relationships and educational resources with local governance in mind.

Beyond Slogans

Supporting careful longevity research, transparent education, and physician-led discussion.

Our Foundation

The principles that guide our mission to make longevity accessible to all

Vision • Mission • Promise

Core Values

Our Team

World-Class Leadership

Led by experienced executives and guided by distinguished advisors

Leadership Team

Operators, scientists, and builders coordinating NovaGen Group's research-led platform.

8 leaders

Diederik van der Reijt, Chief Executive Officer

Diederik van der Reijt

Chief Executive Officer

Diederik van der Reijt is the CEO and Co-founder. A serial biotech entrepreneur and investor, he previously built a successful high-frequency trading firm and co-founded NKore Biotherapeutics, and now leverages his finance and venture capital background to democratize access to breakthrough cellular therapies.

Dr. Yi Eve Sun, Chief Scientific Officer

Dr. Yi Eve Sun

Chief Scientific Officer

Professor, UCLA Department of Molecular & Medical Pharmacology. Pioneer in neural stem cell biology and leading expert in cellular reprogramming. Academic excellence with breakthrough discoveries in JAK-STAT pathways and successful translation from bench to bedside.

Dr. Henk Viëtor, Chief Medical Officer

Dr. Henk Viëtor

Chief Medical Officer

Co-founded and led more than 20 life sciences companies, including Drug Discovery Factory, Skyline Diagnostics, Julius Clinical, DC4U, MyLife Technologies, and Oncodrone. Physician, scientist, and serial biotech entrepreneur with expertise in clinical immunology, transfusion medicine, and genetics.

Karen Brink, Chief Growth Officer

Karen Brink

Chief Growth Officer

Karen Brink leads growth strategy and thought leadership for the company’s cellular longevity platform. An experienced healthcare investor and company founder, she has launched several healthcare ventures and holds a Blockchain Strategy degree from Oxford.

Jimmy Zhu Wenmin, Chief Innovation Officer

Jimmy Zhu Wenmin

Chief Innovation Officer

Seasoned business professional with a strong track record in commercializing innovative healthcare technologies in China. Proven leader in scaling ventures, securing strategic partnerships, and driving global market expansion.

Dr. Digvijay Gahtory, Chief Business Officer

Dr. Digvijay Gahtory

Chief Business Officer

Has over 8 years of experience in strategy consulting and entrepreneurship. Has raised more than €100 million in financing for life science companies. Founder and CEO of Bimini Biotech.

Rhys Tombling, Finance Director

Rhys Tombling

Finance Director

Has 10 years of experience in the private sector, specializing in financial control & operations for start-ups and scale-ups in FMCG and SaaS. Holds an ACA-ICAEW accountancy qualification and a BA in Accountancy and Finance from Newcastle University.

Daniel Erasmus, Chief AI Architect

Daniel Erasmus

Chief AI Architect

He is a member of the OECD's AI Expert Group and CEO of Erasmus.AI, a platform creating domain-specific AI models like ClimateGPT, the world's first foundational Climate Change model. With 25 years of experience in strategy and foresight advisory, he is also a full member of the Club of Rome.

Medical & Scientific Board

Scientific and clinical advisors supporting research context and review.

5 members

Dr. Henry Delmar

Founder Clinique Delmar

Member of the European Board of Plastic Surgeons (EBOPRAS), specializes in Plastic, Reconstructive, and Aesthetic Surgery. President of the French Society of Aesthetic Plastic Surgery (SOFCEP) and member of IPRAS and ESPRAS.

Dr. Pierre Maldiney

Cardiologist & Functional Medicine Doctor

Cardiologist, morphologist, and anti-aging physician with training in nutritional and functional medicine with Professor Vincent Castronovo. President of AEM2F, the European Association of Mitronutrition and Functional Medicine.

Dr. Bas Pijnenburg

Orthopedic Surgeon & Medical Director Acibadem (NL)

Orthopedic surgeon at ACIBADEM International Medical Center with expertise in hip, knee, and ankle conditions, including sports orthopedics and arthroscopic treatment of ankle and knee injuries. He trained in medicine and orthopedics in Amsterdam and completed a PhD on evidence-based diagnosis and treatment of acute ankle injuries.

Doris Rathgeber

Owner, Body & Soul

Founder and Medical Director of Body & Soul in Shanghai. With over 20 years' experience in Traditional Chinese and Western Medicine, specializes in women's health, fertility, and pediatrics, delivering care in four languages.

Dr. Heshan Illangkoon

Biochemist & Regenerative Medicine

Biomedical engineer and translational scientist focused on turning frontier longevity and regenerative medicine research into deployable therapies. Leads NovaGen Group's innovation pipeline, bridging AI-driven discovery, clinical partners, and global research networks.

Advisory Board

Global advisors across finance, partnerships, governance, and cross-border strategy.

8 members

Neil Bush

Strategic/ Cross Border Advisor

Global business leader with 40+ years experience specializing in cross-border investments in Asia and the Middle East. Founder of the George H. W. Bush Foundation for U.S.-China Relations. Chairs Points of Light and the Bush School Advisory Board.

Dr. Nina Storms (h.c.)

Strategic Advisor

Entrepreneur and strategic investor with a background in technology, internet, media, and health ventures. She founded multiple companies, later invested across media and internet companies, and is now involved with NovaGen’s regenerative longevity platform.

Jaap Zuiderveld

Global Technology Advisor

International technology executive with more than 20 years of leadership experience across AI, software, IT, and telecommunications. He has held senior roles at NVIDIA, Colt Technology Services, ACN, Active 24, Versatel, KPN, and British Telecom, with a focus on scaling regional growth and AI adoption.

Dr. Marcel Reichart

Capital Market Advisor

Is a global senior advisor, executive and investor with extensive experience in international corporate development, M&A, board management, capital markets and communications across technology, AI, software, media, blockchain and growth industries.

Stephen Bradley

Advisor

Former British Consul-General to Hong Kong, graduated from Oxford in 1980 and studied at Fudan University. Leverages extensive diplomatic experience across Asia to advise on cross-border consultancy and strategic development. Serves on the boards of Cenovus Energy Inc., CK Asset Holdings, and Power Assets Holdings.

Paul Spiegel

Advisor

International business development executive with extensive experience in Asia-Pacific markets and cross-border partnerships. Specializes in strategic planning and market expansion for biotechnology companies, with deep expertise in regulatory affairs and commercial strategy.

David Bizer

Advisor

Co-founder and Managing Partner of GCW Global Customised Wealth, specializing in private equity and family office investments. Previously held senior positions at Jasper Ridge Partners, Nomura, and Lehman Brothers. Has served as an economic advisor to two U.S. Presidents. Ph.D. in Economics from Stanford University.

Shirin Azad

Advisor

Shirin Azad is Strategic Advisor for Europe where she supports the company’s mission to advance investigational cellular longevity technologies. Based in London, she is an ex-headhunter, investor, and philanthropist with international experience across the UK and Germany, and she brings a strong interest in health, longevity, and patient advocacy to her work.

Important Medical Notice: Content on this website is educational and informational only. NovaGen Group does not provide medical advice, diagnosis, or treatment through this website. Any investigational protocol information should be discussed with qualified, licensed healthcare professionals. Availability and regulatory status vary by jurisdiction.